We have finished a controlled field evaluation of a new Lyme disease serology
product and would like to "beta" test it in several US sites. These kits will
not be sold into the US until FDA cleared. Sites must have reasonable access
to patient history and use serology test methods that include a western blot
analysis using criteria similar to those described by Dressler.
If interested, please contact me at b3748 at cts.com or by FAX at 619-592-9400.
Thanks,
Bryan Kiehl
Bryan Kiehl
GenBio
15222-A Avenue of Science
San Diego, CA 92128
(619) 592-9300, ext 309
(619) 592-9400 [FAX]
